Emerging CAR T-Cell Therapies in Hematologic Cancers

Xiuli Wang, PhD
Published: Thursday, Sep 05, 2019



Xiuli Wang, PhD, research professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, discusses emerging CAR T-cell therapy in hematologic cancers.

Currently available CAR T-cell therapies, although very promising for blood cancers like leukemia and lymphoma, has many challenges, explains Wang. Not all patients respond to CAR T-cell therapy; others might respond but relapse soon after. The reason for these challenges, according to Wang, is that there are not enough CAR T cells in patients.

These newer CAR T cells, which Wang is studying at the City of Hope Comprehensive Cancer Center, allow physicians to expand CAR T cells in patients by using cytomegalovirus (CMV) vaccines. With this new technology, these CAR molecules are introduced into the CMV-specific T cells, allowing the resulting T cells to have 2 specificities; they can recognize tumor and CMV antigens, concludes Wang.
SELECTED
LANGUAGE


Xiuli Wang, PhD, research professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, discusses emerging CAR T-cell therapy in hematologic cancers.

Currently available CAR T-cell therapies, although very promising for blood cancers like leukemia and lymphoma, has many challenges, explains Wang. Not all patients respond to CAR T-cell therapy; others might respond but relapse soon after. The reason for these challenges, according to Wang, is that there are not enough CAR T cells in patients.

These newer CAR T cells, which Wang is studying at the City of Hope Comprehensive Cancer Center, allow physicians to expand CAR T cells in patients by using cytomegalovirus (CMV) vaccines. With this new technology, these CAR molecules are introduced into the CMV-specific T cells, allowing the resulting T cells to have 2 specificities; they can recognize tumor and CMV antigens, concludes Wang.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Publication Bottom Border
Border Publication
x